Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical trial for chronic myelogenous leukemia, with significant changes including the removal of detailed treatment objectives and inclusion criteria, while adding new identifiers and collaborators.SummaryDifference32%
- Check23 days agoChange DetectedThe webpage has updated its contact information for several principal investigators and removed multiple entries related to previous contacts and locations. Additionally, new dates have been added, indicating upcoming events or deadlines.SummaryDifference30%
- Check120 days agoChange DetectedThe website has updated its contact information for study inquiries, replacing the previous list of principal investigators with a new section titled 'Contacts and Locations' that includes numerous site public contacts.SummaryDifference49%
- Check186 days agoChange DetectedThe website has been updated from version v2.11.2 to v2.12.1, indicating a new release with potential improvements or features.SummaryDifference0.2%
- Check203 days agoChange DetectedDifference0.2%
- Check210 days agoChange DetectedDifference0.2%
Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.